Icon

MIPLYFFA (NDA214927)- (EQ 47MG BASE,EQ 62MG BASE,EQ 93MG BASE,EQ 124MG BASE)

ARIMOCLOMOL CITRATE ZEVRA DENMARK
EQ 47MG BASE,EQ 62MG BASE,EQ 93MG BASE,EQ 124MG BASE
No No
2029-Aug-19 2029-Sep-20
None None
None No
MIPLYFFA is indicated for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients 2 years of age and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 47MG BASE ** ** - - -
EQ 62MG BASE ** ** - - -
EQ 93MG BASE ** ** - - -
EQ 124MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.